UnknownNot Applicable

Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction

Egypt100 participantsStarted 2014-09

Plain-language summary

In this study we explore To explore the role of maternal serum vascular endothelial growth factor (VEGF) in pregnancies complicated by foetal growth restriction.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 20-40 years * Gestational age 28-36 weeks * Fetal growth restriction * Patient consents to the procedure. * BMI 20-30 Exclusion Criteria: * Preeclampsia * Diabetes Mellitus * Fetal congenital anomalies

What they're measuring

Obstetric ultrasound

Timeframe: from 28 weeks gestation to 36 weeks gestation

Trial details

NCT IDNCT02245477

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-06

Contact for this trial

Nesreen A Shehata, MD

00201227866337 nesoomar@yahoo.com

View on ClinicalTrials.gov More Foetal Growth Restriction trials